New cancer treatment danger: Pills vulnerable to gastric acid suppressionCanadian researchers find proton pump inhibitors are linked with reduced survival in patients on oral anticancer agents ASA: Cancer fighterBiomarkers explain inconsistent results in colorectal cancer prevention Prostate screening guideline crosses border Canadian study suggests biopsy rates have been dropping since U.S. task force report Hypertension occurs in most patients receiving VEGF inhibitor therapy for cancer Guidelines needed to improve hypertension management without affecting cancer response. Sildenafil linked with melanoma FDA advisers unanimously back Cologuard, a DNA test for colon cancer Experimental therapies target chronic lymphocytic leukemia Monoclonal antibody and kinase inhibitor yield promising results in recent trials Will better treatment phase out breast screening? CNBSS 25-year results question mammography programs Results mixed for bevacizumab in glioblastoma Angiogenesis inhibitor fails to prolong overall survival Giotrif: new oral therapy for metastatic lung cancer Targeted treatment improves progression-free survival and disease related symptoms. First Previous 45 46 47 48 49 Next Last
